Contingency Management with pharmacologic treatment for Stimulant Use Disorders: A review
Abstract
OBJECTIVES: Stimulant Use Disorders (SUDs) are an emergent public health concern in the United States and worldwide. However, there is still a lack of consensus for best-approaches regarding treatment of SUD. Recent trials have evaluated combinations of medications and psychosocial treatments to enhance efficacy. Contingency Management (CM) is a behavioral intervention that has shown effectiveness in treating SUDs. Our aim was to review studies using a combined methods approach such as CM and medications for the treatment of SUD.
DESIGN: We performed a qualitative literature review of clinical trials that combined CM with any pharmacological treatment for SUDs.
RESULTS: Among twenty-one publications included, ten reviewed a combination of CM and medications was superior to each intervention alone. In three of studies patients receiving CM showed better outcomes than those with no CM, regardless of their medication status. In one, groups receiving medication with or without CM had better outcomes than groups that received no medication. Finally, seven of the studies found no difference in the outcomes of interest for either CM, medication, or the combination of CM and medication.
CONCLUSIONS: CM and medication as treatment for SUD could act synergistically and enhance each other's effect. Combining CM and medications may be a key strategy for effective SUD treatment. Future studies should further investigate the efficacy of the combined approach of medications and CM.
Read the paper
Related studies
- Combining in silico and in vitro approaches to identification of potent inhibitor against phospholipase A2 (PLA2)
- In silico and in vitro studies: investigating the chemical composition, DFT, molecular docking, and dynamic simulation of Satureja candidissima (Munby) Briq essential oil as a potential antibacterial agent
- Quercetin combined with ciprofloxacin and gentamicin inhibits biofilm formation and virulence in Staphylococcus aureus
- In silico study of the mechanism of action, pharmacokinetic and toxicological properties of some N-methylanthranilates and their analogs
- Anticonvulsant Effects of Citronellal, Daidzin, and Phytol, Possibly Through GABAA Receptor and Voltage-Gated Sodium Channel Interaction Pathways: In Vivo and In Silico Studies
- 2-Phenylcyclopropylmethylamine (PCPMA) Derivatives as D3R-Selective Ligands for 3D-QSAR, Docking and Molecular Dynamics Simulation Studies
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.